Growth Metrics

Larimar Therapeutics (LRMR) Depreciation and Depletion (2016 - 2020)

Historic Depreciation and Depletion for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to $50000.0.

  • Larimar Therapeutics' Depreciation and Depletion rose 15000.0% to $50000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $155000.0, marking a year-over-year increase of 9871.79%. This contributed to the annual value of $318000.0 for FY2024, which is 225.08% up from last year.
  • Latest data reveals that Larimar Therapeutics reported Depreciation and Depletion of $50000.0 as of Q4 2020, which was up 15000.0% from $50000.0 recorded in Q3 2020.
  • In the past 5 years, Larimar Therapeutics' Depreciation and Depletion registered a high of $107000.0 during Q3 2018, and its lowest value of -$13000.0 during Q2 2019.
  • Its 5-year average for Depreciation and Depletion is $44700.0, with a median of $50000.0 in 2016.
  • Per our database at Business Quant, Larimar Therapeutics' Depreciation and Depletion soared by 90000.0% in 2016 and then plummeted by 12500.0% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Depreciation and Depletion (Quarter) stood at $61000.0 in 2016, then decreased by 18.03% to $50000.0 in 2017, then increased by 4.0% to $52000.0 in 2018, then plummeted by 61.54% to $20000.0 in 2019, then skyrocketed by 150.0% to $50000.0 in 2020.
  • Its last three reported values are $50000.0 in Q4 2020, $50000.0 for Q3 2020, and $32000.0 during Q2 2020.